NDC Package 82584-003-30 Iyuzeh

Latanoprost Ophthalmic Solution 0.005% Solution/ Drops Ophthalmic - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
82584-003-30
Package Description:
30 POUCH in 1 CARTON / .2 mL in 1 POUCH
Product Code:
Proprietary Name:
Iyuzeh
Non-Proprietary Name:
Latanoprost Ophthalmic Solution 0.005%
Substance Name:
Latanoprost
Usage Information:
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
11-Digit NDC Billing Format:
82584000330
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2642284 - IYUZEH 0.005 % Ophthalmic Solution
  • RxCUI: 2642284 - latanoprost 0.05 MG/ML Ophthalmic Solution [Iyuzeh]
  • RxCUI: 2642284 - Iyuzeh 0.005 % Ophthalmic Solution
  • RxCUI: 314072 - latanoprost 0.005 % Ophthalmic Solution
  • RxCUI: 314072 - latanoprost 0.05 MG/ML Ophthalmic Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Thea Pharma Inc.
    Dosage Form:
    Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
    Administration Route(s):
  • Ophthalmic - Administration to the external eye.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA216472
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    07-14-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 82584-003-30?

    The NDC Packaged Code 82584-003-30 is assigned to a package of 30 pouch in 1 carton / .2 ml in 1 pouch of Iyuzeh, a human prescription drug labeled by Thea Pharma Inc.. The product's dosage form is solution/ drops and is administered via ophthalmic form.

    Is NDC 82584-003 included in the NDC Directory?

    Yes, Iyuzeh with product code 82584-003 is active and included in the NDC Directory. The product was first marketed by Thea Pharma Inc. on July 14, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 82584-003-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 82584-003-30?

    The 11-digit format is 82584000330. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-282584-003-305-4-282584-0003-30